Skip to main content
Clinical Trials/NCT00659633
NCT00659633
Completed
Not Applicable

The Effect of Intravenous Lidocaine on Allodynia (Carl Koller Grant)

University of Alabama at Birmingham1 site in 1 country10 target enrollmentDecember 2008
ConditionsPain
Interventionslidocaine

Overview

Phase
Not Applicable
Intervention
lidocaine
Conditions
Pain
Sponsor
University of Alabama at Birmingham
Enrollment
10
Locations
1
Primary Endpoint
Pain Perception
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to study if lidocaine, given intravenously, reduces pain.

Detailed Description

Clinicians use lidocaine intravenously in a fashion that suggests that it might have analgesic effects. Therefore, we test the hypothesis that lidocaine reduces pain intensity in response to experimental pain.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
August 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Froelich

Associate Proffesor Anesthesiology M.D.

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Chronic Regional Pain Syndrome diagnostic criteria by the Work Safe BC. vi

Exclusion Criteria

  • History of Substance abuse
  • Other Medications: CRPS patients are expected to be treated for chronic pain, whether the current treatment regimen interferes with sensory motor testing will be determined on a case by case basis.
  • Coronary Artery Disease (CAD): unstable
  • Congestive Heart Failure (CHF): unstable
  • Heart Arrhythmia: symptomatic
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lidocaine Allergy
  • Diagnostic and Statistical Manual of Mental Disorders (Rev IV): Axis I: Common Axis I disorders include depression, anxiety disorders, bipolar disorder, ADHD, and schizophrenia. Axis II: borderline personality disorder, schizotypal personality disorder, antisocial personality disorder, and mild mental retardation.
  • Presence of Contraindications for MRI
  • Presence of electronically, magnetically, and mechanically activated implants

Arms & Interventions

Lidocaine

Intravenous lidocaine for neuropathic pain

Intervention: lidocaine

Outcomes

Primary Outcomes

Pain Perception

Time Frame: Participants will be followed from baseline through 128 minutes

Assessing heat pain perception (pain intensity) before, during, and after lidocaine infusion by means of patient self-report using a mechanical slide algometer. The mechanical slide algometer \[Price et al. (1994)\] looks like a ruler that exposes a red bar with the end-points: no pain (left) and most pain imaginable (right). The use the slider to express their perceived pain. On the back of the ruler a numerical scale ranging from 0 (no pain) to 10 (worst imaginable pain) translates the patient's rating into a numeric scale.

Study Sites (1)

Loading locations...

Similar Trials